/
CNMD
$34.41-$1.54 (-4.28%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$1.1B
30M shares
52-week range
$31.44 – $56.64
12% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-103.02
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $859.6M | $955.1M | $862.5M | $1.01B | $1.05B | $1.24B | $1.31B | $1.37B |
| Cost of revenue | $390.5M | $430.4M | $402.2M | $442.6M | $474.2M | $568.5M | $574.0M | $649.1M |
| Gross profit | $469.1M | $524.7M | $460.3M | $568.0M | $571.2M | $676.2M | $733.0M | $725.4M |
| Gross margin | 54.6% | 54.9% | 53.4% | 56.2% | 54.6% | 54.3% | 56.1% | 52.8% |
| R&D | $42.2M | $45.5M | $40.5M | $43.6M | $47.2M | $52.6M | $54.4M | $55.9M |
| Operating income | $71.3M | $79.1M | $46.0M | $109.7M | $70.1M | $120.6M | $200.3M | $141.1M |
| EBITDA | $133.1M | $146.2M | $118.3M | $179.3M | $7.8M | $192.5M | $272.2M | $154.5M |
| Net income | $40.9M | $28.6M | $9.5M | $62.5M | −$80.6M | $64.5M | $132.4M | $47.1M |
| Net margin | 4.8% | 3.0% | 1.1% | 6.2% | -7.7% | 5.2% | 10.1% | 3.4% |
| EPS (diluted) | 1.41 | 0.97 | 0.32 | 1.94 | -2.68 | 2.04 | 4.26 | 1.51 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.4B | $4.37 | $4.34–$4.38 | 3 |
| 2027 | $1.4B | $4.79 | $4.63–$4.94 | 3 |
| 2028 | $1.5B | $5.43 | $5.40–$5.47 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$132.95
Price
$34.41
Implied upside
+286%
Peer comparison
CONMED Corporation
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
www.conmed.com- Employees
- 3,900
- IPO / List date
- Jul 23, 1987
- HQ
- LARGO, FL
Held by traders on TradeandTell
No one on the platform currently holds CNMD.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-09-30 | 76,581 | $5.5M |
| Bridgewater Associatesas of 2025-09-30 | 5,933 | $279.0K |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.32% ($0.80/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-09-15 | $0.2000 | 2025-10-03 |
| 2025-06-13 | $0.2000 | 2025-07-03 |
| 2025-03-14 | $0.2000 | 2025-04-04 |
| 2024-12-20 | $0.2000 | 2025-01-03 |
| 2024-09-16 | $0.2000 | 2024-10-04 |
| 2024-06-14 | $0.2000 | 2024-07-05 |
| 2024-03-14 | $0.2000 | 2024-04-05 |
| 2023-12-15 | $0.2000 | 2024-01-05 |
| 2023-09-14 | $0.2000 | 2023-10-05 |
Recent trades on TradeandTell
No one on the platform has traded CNMD yet.
